The only direct, swift and accurate way to measure total blood volume and red blood cell volume in the clinical setting

Read More

Key Features

  • Actionable results with 98% accuracy
  • Quantifies the excess or deficit vs patient-specific ideal
  • Non-invasive, single-venipuncture technique

Latest News

Daxor Corporation Announces Share Buyback Program

New York, NY November 1, 2017 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announced today that an updated buyback program has been unanimously approved by Daxor’s Board of Directors. The Board of Directors of Daxor has voted to re-authorize the company’s share buyback for an amount of […]

Read More

Daxor Corporation Holds Annual Meeting Provides Business Growth Update and Strategic Plan

New York, NY June 29, 2017 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, (NYSE:DXR) held its annual meeting on June 27th in New York City, where it briefed investors on its progress in growing its medical technology operating company supplying the Daxor BVA-100 blood volume analysis device. […]

Read More

Daxor Corporation Announces Reinstatement of Compliance with the New York Stock Exchange (NYSE MKT LLC)

New York, NY June 26, 2017 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, received a letter from the New York Stock Exchange informing Michael Feldschuh, President and Chief Executive Officer of Daxor Corporation, that the Company is “Back in compliance with the NYSE MKT LLC continued listing […]

Read More

Daxor Corporation Announces Death of Founder, Chief Medical Officer, and Developer of Blood Volume Analysis and Inventor the Daxor BVA-100 Device, Dr. Joseph Feldschuh

New York, NY February 1, 2017 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, sadly announced today the death of the Company’s founder and its first President and Chief Executive Officer, Dr. Joseph Feldschuh. Dr Feldschuh, who was working on a part-time basis and responding well treatment for […]

Read More